Auranofin’s anti-cancer activity has been linked to the accumulation of ROS via the inhibition of the redox enzymes, GPx and TrxR, which play important roles in the glutathione and thioredoxin redox systems, respectively (55, 84, 85). The gene discussed is TXN; the disease is cancer.